Cloud-based electronic laboratory notebook designed for chemistry, biology, formulations, and materials science research in pharma and life sciences organizations.
Dotmatics ELN & Data Discovery Platform is a browser-based electronic laboratory notebook engineered for complex scientific workflows across multiple disciplines including synthetic and analytical chemistry, molecular and screening biology, formulations, and materials science. The platform supports peptides, oligos, biologics, and small molecule chemistry research in a single integrated system.
The solution provides configurable experiment templates, chemical and biological registration capabilities (Register and Bioregister), and federated data search functionality through Dotmatics Browser. It enables researchers to capture, organize, and search experimental data while maintaining FDA 21 CFR Part 11 compliance with electronic signatures, audit trails, and validation documentation.
Dotmatics ELN offers both cloud-hosted and on-premise deployment options with role-based access controls and mobile device support. The platform integrates with broader R&D ecosystems including LIMS, screening tools, analytics platforms, and 100+ lab instruments through Lab Connect. Cloud deployments support external collaborations with bi-directional data flows and experiment transfer capabilities between partners.
The platform is positioned as part of Dotmatics' comprehensive scientific data management portfolio, serving more than 2 million researchers across 14,000+ customers globally, with particular strength in pharmaceutical and biotechnology organizations.
Dotmatics ELN offers flexible deployment options including cloud-hosted SaaS and on-premise installations. The platform is browser-based and browser-agnostic, providing access from desktop and mobile devices without requiring specific client software or VPN for cloud deployments.
Cloud deployments support secure external collaborations with bi-directional data flows between organizations. The platform provides AES-256 encryption, role-based access controls, and self-service Trust Center for security transparency. Integration capabilities include connection to 100+ lab instruments through Lab Connect, federated search across Dotmatics and third-party databases, and data exchange with other Dotmatics applications including LIMS, experiment registration, screening tools, and analytics platforms.
The system is classified as GAMP 5 Category 4 (Configured Product), supporting end-user workflow configuration without custom or bespoke components to maintain lower validation risk. REST API availability and specific cloud provider details (AWS, Azure, GCP) are undisclosed.
Pricing is not publicly disclosed and requires custom quotes from the vendor. Third-party market analysis of Dotmatics-owned products puts corporate ELN implementations at $575–675 per user annually for basic configurations; full Dotmatics platform deployments with multiple modules reach significantly higher annual costs for enterprise implementations.
Subscription-based, per-user pricing with no large upfront investment. Customers select specific functionality modules and pay based on user count, allowing licensing to scale as teams grow. Annual subscription contracts are standard, with pricing varying by user count, modules selected, deployment option (cloud vs on-premise), and implementation complexity.
Academic pricing is substantially lower than corporate pricing, with academic site licences available. Enterprise deployments combining ELN with other Dotmatics modules (LIMS, data analytics, instrument integration) reach the high tens or hundreds of thousands of dollars annually for mid-sized teams.
Trial and demo availability is undisclosed.
Dotmatics provides implementation support and validation assistance as part of its professional services offering. The GAMP 5 Category 4 classification requires customer-led validation with vendor support, and Dotmatics works with customers to configure the software based on industry best practices while remaining compliant with regulatory requirements.
The platform supports experiment template migration and data import capabilities, though specific timeline information for typical implementations is undisclosed. Charles River Laboratories deployed Dotmatics ELN to 500 researchers across UK and Netherlands operations, indicating the system can scale for large multi-site implementations.
Cloud-hosted deployments enable faster time-to-value compared to on-premise installations. The vendor provides training and professional services to support adoption, and works closely with customers on configuration and workflow optimization.
Anonymous feedback from pharmaceutical professionals using this solution
4.6 out of 5
Based on 13 verified reviews
Users appreciate Dotmatics ELN for improving research throughput and productivity in chemistry and biology workflows. Charles River Laboratories noted that the solution helps optimise in-house processes while better serving their clients. The platform is recognised for enhancing productivity and collaboration in R&D teams, particularly for rare disease gene therapy development. Recently enhanced user interface and simplified navigation improvements were developed through close customer collaboration, addressing user experience feedback. Users value the platform's ability to handle large volumes of scientific data: one pharma mass-spec facility processes 700GB–1TB of files per week, replacing a previous two-to-three-day manual process. The platform offers configurable templates for multiple scientific disciplines and integration capabilities across the Dotmatics ecosystem.
Independent third-party review data is limited, constraining detailed analysis of user complaints and pain points. Dotmatics does not publish pricing information and requires extensive custom quotes that vary significantly based on configuration. Enterprise deployment costs may present budget challenges for smaller organisations or academic institutions, though academic pricing is available at reduced rates. As a GAMP 5 Category 4 system, customers must lead their own validation efforts with vendor support, which may require additional internal resources. Detailed user reviews are not publicly available, limiting assessment of common pain points, implementation challenges, or areas where the product may fall short of expectations.
Share your experience with Dotmatics ELN anonymously. Your insights help pharmaceutical professionals make better software decisions.
Contribute Anonymous FeedbackPublicly disclosed pharmaceutical and biotech organizations
Jump to section